Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Maryland

Phase 1 cancer trials in Maryland

91 Phase 1 cancer studies are recruiting participants at sites in 9 cities across Maryland as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Maryland city with a recruiting study

By research area: Lung Cancer (31), Lymphoma (26), Breast Cancer (16), Prostate Cancer (12), Pancreatic Cancer (5), Melanoma (1).

Baltimore (50), Bethesda (30), Glen Burnie (7), Calverton (2), Rockville (2), Annapolis (1), Bel Air (1), Silver Spring (1), Towson (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Maryland

Basic details from each study's public record (the 12 most recently updated of 91). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

    • Phase 1
    • Ages 12 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT04222413 · updated
  2. A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Totus Medicines
    Recruiting in
    Calverton
    Registry record
    NCT05683418 · updated
  3. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Recruiting in
    Glen Burnie
    Registry record
    NCT07020117 · updated
  4. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Recruiting in
    Baltimore
    Registry record
    NCT06638307 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Maryland on ClinicalTrials.gov.

Lung cancer: recently updated in Maryland

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Baltimore
    Registry record
    NCT06287775 · updated
  2. A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

    • Phase 1
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT06066138 · updated
  3. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Baltimore
    Registry record
    NCT07020221 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Maryland on ClinicalTrials.gov.

Prostate cancer: recently updated in Maryland

  1. Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

    • Phase 1/2
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT07667400 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Maryland on ClinicalTrials.gov.

Lymphoma: recently updated in Maryland

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Baltimore
    Registry record
    NCT04726241 · updated
  2. Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

    • Early Phase 1
    • Ages 18 to 100
    • All sexes
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting in
    Bethesda
    Registry record
    NCT07428707 · updated
  3. Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 1
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT07572136 · updated
  4. Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

    • Phase 1/2
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT03223610 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Maryland on ClinicalTrials.gov.

Ask about studies in Maryland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call